Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Cash Flows

v3.24.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities    
Net loss $ (7,937,011) $ (8,154,113)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 249,592 10,182
Accretion of debt issuance costs 2,055,627
Fair value adjustments on convertible notes payable 1,866,922
Stock-based compensation expense 748,823 248,592
Fair value of warrants issued
Gain on extinguishment of debt (212,258)
Changes in operating assets and liabilities:    
Accounts and other receivables 311,366 (8,959)
Inventory (12,944) (5,540)
Prepaid expenses and other assets 214,402 (492,753)
Accounts payable (14,501) 114,635
Accrued expenses 362,012 66,335
Unearned revenue 33,058
Accrued interest 440,485
Operating lease right-of-use asset 7,397
Net cash used in operating activities (6,037,806) (4,070,845)
Cash flows from investing activities    
Purchase of property and equipment (22,902) (219,987)
Acquisition, net of cash acquired (2,186,497)
Net cash used in investing activities (2,209,399) (219,987)
Cash flows from financing activities    
Proceeds from loan payable (251,746) 555,148
Payment on loans payable (269,983)
Proceeds from issuance of convertible notes payable 724,000
Repayment of convertible loan payable (425,000)
Proceeds from issuance of common stock from the initial public offering, net of underwriting discounts, commissions and offering expenses of approximately $1.8 million 6,027,414
Exercise of warrants 7,713,310
Exercise of stock options 74,900
Return of capital from stock split (185)
Payment of debt issuance costs (55,651)
Principle repayments on finance leases (93,238)
Net cash provided (used) by financing activities (344,984) 14,343,953
Net increase (decrease) in cash and cash equivalents (8,592,189) 10,053,121
Cash and cash equivalents at beginning of year 11,413,759 1,360,638
Cash and cash equivalents at end of year 2,821,570 11,413,759
Supplemental disclosures of cash flow information:    
Income taxes paid in cash 20,993 30,637
Interest paid 37,125 2,459
Noncash investing activities:    
Stock issuance in connection with the acquisition 1,000,000
Noncash financing activities:    
Conversion of convertible preferred stock into common stock 4,044,318
Conversion of convertible notes payable into common stock 16,065,332
Fair value of warrants issued to placement agents 352,250
Beneficial conversion feature for bridge notes $ 462,344